The Guardian: New drugs could ease Myanmar’s crippling tuberculosis burden
“…Now, there is new hope for patients. This month, Médecins Sans Frontières (MSF) and the National TB Programme (NTP) will start treating people with bedaquiline and delamanid. These are the first new TB drugs for half a century and it is hoped they will be effective in treating patients who have developed resistance to existing drugs or cannot handle the side-effects…” (Arnold, 3/24).

Huffington Post: He Looks At Tuberculosis Death Toll And Wonders Why You’re Not Worried
“Aaron Motsoaledi is tired of delivering the same spiel over and over again. No matter how many times the charismatic health minister of South Africa speaks out, people don’t seem to grasp the threat presented by tuberculosis, now the No. 1 infectious killer in the world…” (Weber, 3/24).

U.N. News Centre: Fight against tuberculosis only ‘half-won,’ U.N. chief says on World Day
“Observing World Tuberculosis Day, United Nations Secretary-General Ban Ki-moon called for united global efforts to end the deadly disease by 2030 as it would claim the lives of 1.5 million people this year alone…” (3/24).

VOA News: WHO: Tuberculosis Can Be Ended by 2030
“…Director of WHO’s Global TB Program, Mario Raviglione, says several of the 30 countries with the highest TB burden are implementing newer TB strategies with some success. One such country is India, home to more people ill with TB and multidrug-resistant TB than any other country in the world…” (Schlein, 3/22).

Wall Street Journal: Tuberculosis Cases in U.S. Rise for First Time in 23 Years
“Tuberculosis is no longer on the decline in the U.S., after nearly a quarter century of steady reductions in cases of the deadly airborne disease, according to federal data released Thursday…” (McKay, 3/24).

Washington Post: TB cases increase in U.S. for first time in 23 years
“… ‘After two decades of declining incidence, progress toward TB elimination in the United States appears to have stalled,’ the CDC report said. The causes are unclear, it said, and the data need further evaluation if the reasons behind the trend are to be identified. One contributing factor is likely to be reduced or stagnant funding for prevention efforts nationwide…” (Sun, 3/24).